BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 26199348)

  • 1. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
    J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
    Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal kappa free light chains as markers for multiple sclerosis.
    Vecchio D; Bellomo G; Serino R; Virgilio E; Lamonaca M; Dianzani U; Cantello R; Comi C; Crespi I
    Sci Rep; 2020 Nov; 10(1):20329. PubMed ID: 33230241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
    Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis.
    Duranti F; Pieri M; Centonze D; Buttari F; Bernardini S; Dessi M
    J Neuroimmunol; 2013 Oct; 263(1-2):116-20. PubMed ID: 23916392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
    Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
    Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
    Senel M; Tumani H; Lauda F; Presslauer S; Mojib-Yezdani R; Otto M; Brettschneider J
    PLoS One; 2014; 9(4):e88680. PubMed ID: 24695382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal immunoglobulin synthesis: The potential value of an adjunct test.
    Emersic A; Anadolli V; Krsnik M; Rot U
    Clin Chim Acta; 2019 Feb; 489():109-116. PubMed ID: 30529605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
    Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
    PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
    Leurs CE; Twaalfhoven H; Lissenberg-Witte BI; van Pesch V; Dujmovic I; Drulovic J; Castellazzi M; Bellini T; Pugliatti M; Kuhle J; Villar LM; Alvarez-Cermeño JC; Alvarez-Lafuente R; Hegen H; Deisenhammer F; Walchhofer LM; Thouvenot E; Comabella M; Montalban X; Vécsei L; Rajda C; Galimberti D; Scarpini E; Altintas A; Rejdak K; Frederiksen JL; Pihl-Jensen G; Jensen P; Khalil M; Voortman MM; Fazekas F; Saiz A; La Puma D; Vercammen M; Vanopdenbosch L; Uitdehaag B; Killestein J; Bridel C; Teunissen C
    Mult Scler; 2020 Jul; 26(8):912-923. PubMed ID: 31066634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.
    Vasilj M; Kes VB; Vrkic N; Vukasovic I
    Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation.
    Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
    J Neurochem; 2021 Nov; 159(3):618-628. PubMed ID: 34478561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.
    Duell F; Evertsson B; Al Nimer F; Sandin Å; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32527760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
    Presslauer S; Milosavljevic D; Huebl W; Parigger S; Schneider-Koch G; Bruecke T
    PLoS One; 2014; 9(2):e89945. PubMed ID: 24651567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.